Skip to main content
bioRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search
New Results

The role of SOX9 in non-small cell lung cancer progression is histopathology-selective

Jie Bao, Katja Närhi, Ana Teodòsio, Annabrita Hemmes, Nora M Linnavirta, Mikko I Mäyränpää, Kaisa Salmenkivi, John Le Quesne, View ORCID ProfileEmmy W Verschuren
doi: https://doi.org/10.1101/2020.11.23.393926
Jie Bao
1Institute for Molecular Medicine Finland, HiLIFE, University of Helsinki, Helsinki, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katja Närhi
1Institute for Molecular Medicine Finland, HiLIFE, University of Helsinki, Helsinki, Finland
2GlaxoSmithKline, Espoo, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ana Teodòsio
3MRC Toxicology Unit, University of Cambridge, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Annabrita Hemmes
1Institute for Molecular Medicine Finland, HiLIFE, University of Helsinki, Helsinki, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nora M Linnavirta
1Institute for Molecular Medicine Finland, HiLIFE, University of Helsinki, Helsinki, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mikko I Mäyränpää
4HUSLAB, Division of Pathology, Helsinki University Hospital, Helsinki, Finland
5Department of Pathology, University of Helsinki, Helsinki, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kaisa Salmenkivi
5Department of Pathology, University of Helsinki, Helsinki, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Le Quesne
3MRC Toxicology Unit, University of Cambridge, United Kingdom
6Leicester Cancer Research Centre, University of Leicester, Leicester, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emmy W Verschuren
1Institute for Molecular Medicine Finland, HiLIFE, University of Helsinki, Helsinki, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Emmy W Verschuren
  • For correspondence: emmy.verschuren@helsinki.fi
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Preview PDF
Loading

Article usage

Article usage: November 2020 to May 2022

AbstractFullPdf
Nov 20204042149
Dec 20201672155
Jan 202143325
Feb 20212886
Mar 202128813
Apr 2021251015
May 2021181615
Jun 20212065
Jul 202113212
Aug 202117275
Sep 202124623
Oct 20217120
Nov 202124816
Dec 2021721
Jan 20221704
Feb 20221141
Mar 202210310
Apr 20221408
May 20221139
Back to top
PreviousNext
Posted November 24, 2020.
Download PDF
Email

Thank you for your interest in spreading the word about bioRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
The role of SOX9 in non-small cell lung cancer progression is histopathology-selective
(Your Name) has forwarded a page to you from bioRxiv
(Your Name) thought you would like to see this page from the bioRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
The role of SOX9 in non-small cell lung cancer progression is histopathology-selective
Jie Bao, Katja Närhi, Ana Teodòsio, Annabrita Hemmes, Nora M Linnavirta, Mikko I Mäyränpää, Kaisa Salmenkivi, John Le Quesne, Emmy W Verschuren
bioRxiv 2020.11.23.393926; doi: https://doi.org/10.1101/2020.11.23.393926
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
The role of SOX9 in non-small cell lung cancer progression is histopathology-selective
Jie Bao, Katja Närhi, Ana Teodòsio, Annabrita Hemmes, Nora M Linnavirta, Mikko I Mäyränpää, Kaisa Salmenkivi, John Le Quesne, Emmy W Verschuren
bioRxiv 2020.11.23.393926; doi: https://doi.org/10.1101/2020.11.23.393926

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Cancer Biology
Subject Areas
All Articles
  • Animal Behavior and Cognition (3514)
  • Biochemistry (7367)
  • Bioengineering (5346)
  • Bioinformatics (20325)
  • Biophysics (10045)
  • Cancer Biology (7776)
  • Cell Biology (11352)
  • Clinical Trials (138)
  • Developmental Biology (6453)
  • Ecology (9980)
  • Epidemiology (2065)
  • Evolutionary Biology (13356)
  • Genetics (9373)
  • Genomics (12614)
  • Immunology (7725)
  • Microbiology (19103)
  • Molecular Biology (7465)
  • Neuroscience (41153)
  • Paleontology (301)
  • Pathology (1235)
  • Pharmacology and Toxicology (2142)
  • Physiology (3178)
  • Plant Biology (6880)
  • Scientific Communication and Education (1276)
  • Synthetic Biology (1900)
  • Systems Biology (5328)
  • Zoology (1091)